iScience (Dec 2021)
Generation and analysis of innovative genomically humanized knockin SOD1, TARDBP (TDP-43), and FUS mouse models
- Anny Devoy,
- Georgia Price,
- Francesca De Giorgio,
- Rosie Bunton-Stasyshyn,
- David Thompson,
- Samanta Gasco,
- Alasdair Allan,
- Gemma F. Codner,
- Remya R. Nair,
- Charlotte Tibbit,
- Ross McLeod,
- Zeinab Ali,
- Judith Noda,
- Alessandro Marrero-Gagliardi,
- José M. Brito-Armas,
- Muhammet M. Öztürk,
- Michelle Simon,
- Edward O'Neill,
- Sam Bryce-Smith,
- Jackie Harrison,
- Gemma Atkins,
- Silvia Corrochano,
- Michelle Stewart,
- Lydia Teboul,
- Abraham Acevedo-Arozena,
- Elizabeth M.C. Fisher,
- Thomas J. Cunningham
Affiliations
- Anny Devoy
- Department of Neuromuscular Diseases, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK
- Georgia Price
- UK MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK
- Francesca De Giorgio
- Department of Neuromuscular Diseases, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK
- Rosie Bunton-Stasyshyn
- Department of Neuromuscular Diseases, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK; UK MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK
- David Thompson
- UK MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK
- Samanta Gasco
- UK MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK
- Alasdair Allan
- UK MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK
- Gemma F. Codner
- UK MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK
- Remya R. Nair
- UK MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK
- Charlotte Tibbit
- UK MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK
- Ross McLeod
- UK MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK
- Zeinab Ali
- UK MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK
- Judith Noda
- Research Unit, Hospital Universitario de Canarias; ITB-ULL and CIBERNED, 38320 La Laguna, Spain
- Alessandro Marrero-Gagliardi
- Research Unit, Hospital Universitario de Canarias; ITB-ULL and CIBERNED, 38320 La Laguna, Spain
- José M. Brito-Armas
- Research Unit, Hospital Universitario de Canarias; ITB-ULL and CIBERNED, 38320 La Laguna, Spain
- Muhammet M. Öztürk
- Department of Neuromuscular Diseases, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK
- Michelle Simon
- UK MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK
- Edward O'Neill
- UK MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK
- Sam Bryce-Smith
- Department of Neuromuscular Diseases, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK
- Jackie Harrison
- UK MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK
- Gemma Atkins
- UK MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK
- Silvia Corrochano
- UK MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK
- Michelle Stewart
- UK MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK
- Lydia Teboul
- UK MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK
- Abraham Acevedo-Arozena
- Research Unit, Hospital Universitario de Canarias; ITB-ULL and CIBERNED, 38320 La Laguna, Spain; Corresponding author
- Elizabeth M.C. Fisher
- Department of Neuromuscular Diseases, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK; Corresponding author
- Thomas J. Cunningham
- UK MRC Harwell Institute, Harwell Campus, Oxfordshire OX11 0RD, UK; Corresponding author
- Journal volume & issue
-
Vol. 24,
no. 12
p. 103463
Abstract
Summary: Amyotrophic lateral sclerosis/frontotemporal dementia (ALS/FTD) is a fatal neurodegenerative disorder, and continued innovation is needed for improved understanding and for developing therapeutics. We have created next-generation genomically humanized knockin mouse models, by replacing the mouse genomic region of Sod1, Tardbp (TDP-43), and Fus, with their human orthologs, preserving human protein biochemistry and splicing with exons and introns intact. We establish a new standard of large knockin allele quality control, demonstrating the utility of indirect capture for enrichment of a genomic region of interest followed by Oxford Nanopore sequencing. Extensive analysis shows that homozygous humanized animals only express human protein at endogenous levels. Characterization of humanized FUS animals showed that they are phenotypically normal throughout their lifespan. These humanized strains are vital for preclinical assessment of interventions and serve as templates for the addition of coding or non-coding human ALS/FTD mutations to dissect disease pathomechanisms, in a physiological context.